Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 145 to 153 of 153 entries
Sorted by: Best Match Show Resources per page
Aquatic Hyphomycete Taxonomic Relatedness Translates into Lower Genetic Divergence of the Nitrate Reductase Gene.

Journal of fungi (Basel, Switzerland)

Mariz J, Franco-Duarte R, Cássio F, Pascoal C, Fernandes I.
PMID: 34947048
J Fungi (Basel). 2021 Dec 11;7(12). doi: 10.3390/jof7121066.

Aquatic hyphomycetes are key microbial decomposers in freshwater that are capable of producing extracellular enzymes targeting complex molecules of leaf litter, thus, being crucial to nutrient cycling in these ecosystems. These fungi are also able to assimilate nutrients (e.g.,...

Cite
Mariz J, Franco-Duarte R, Cássio F, et al. Aquatic Hyphomycete Taxonomic Relatedness Translates into Lower Genetic Divergence of the Nitrate Reductase Gene. J Fungi (Basel). 2021;7(12)doi: 10.3390/jof7121066.
Mariz, J., Franco-Duarte, R., Cássio, F., Pascoal, C., & Fernandes, I. (2021). Aquatic Hyphomycete Taxonomic Relatedness Translates into Lower Genetic Divergence of the Nitrate Reductase Gene. Journal of fungi (Basel, Switzerland), 7(12), . https://doi.org/10.3390/jof7121066
Mariz, Joana, et al. "Aquatic Hyphomycete Taxonomic Relatedness Translates into Lower Genetic Divergence of the Nitrate Reductase Gene." Journal of fungi (Basel, Switzerland) vol. 7,12 (2021). doi: https://doi.org/10.3390/jof7121066
Mariz J, Franco-Duarte R, Cássio F, Pascoal C, Fernandes I. Aquatic Hyphomycete Taxonomic Relatedness Translates into Lower Genetic Divergence of the Nitrate Reductase Gene. J Fungi (Basel). 2021 Dec 11;7(12). doi: 10.3390/jof7121066. PMID: 34947048.
Copy Download .nbib Format: NLM
A Boron Delivery Antibody (BDA) with Boronated Specific Residues: New Perspectives in Boron Neutron Capture Therapy from an In Silico Investigation.

Cells

Rondina A, Fossa P, Orro A, Milanesi L, De Palma A, Perico D, Mauri PL, D'Ursi P.
PMID: 34831449
Cells. 2021 Nov 18;10(11). doi: 10.3390/cells10113225.

Boron Neutron Capture Therapy (BNCT) is a tumor cell-selective radiotherapy based on a nuclear reaction that occurs when the isotope boron-10 (

Cite
Rondina A, Fossa P, Orro A, et al. A Boron Delivery Antibody (BDA) with Boronated Specific Residues: New Perspectives in Boron Neutron Capture Therapy from an In Silico Investigation. Cells. 2021;10(11)doi: 10.3390/cells10113225.
Rondina, A., Fossa, P., Orro, A., Milanesi, L., De Palma, A., Perico, D., Mauri, P. L., & D'Ursi, P. (2021). A Boron Delivery Antibody (BDA) with Boronated Specific Residues: New Perspectives in Boron Neutron Capture Therapy from an In Silico Investigation. Cells, 10(11), . https://doi.org/10.3390/cells10113225
Rondina, Alessandro, et al. "A Boron Delivery Antibody (BDA) with Boronated Specific Residues: New Perspectives in Boron Neutron Capture Therapy from an In Silico Investigation." Cells vol. 10,11 (2021). doi: https://doi.org/10.3390/cells10113225
Rondina A, Fossa P, Orro A, Milanesi L, De Palma A, Perico D, Mauri PL, D'Ursi P. A Boron Delivery Antibody (BDA) with Boronated Specific Residues: New Perspectives in Boron Neutron Capture Therapy from an In Silico Investigation. Cells. 2021 Nov 18;10(11). doi: 10.3390/cells10113225. PMID: 34831449; PMCID: PMC8618907.
Copy Download .nbib Format: NLM
Structural, Thermal, and Vibrational Properties of N,N-Dimethylglycine-Chloranilic Acid-A New Co-Crystal Based on an Aliphatic Amino Acid.

Materials (Basel, Switzerland)

Hetmańczyk J, Hetmańczyk Ł, Nowicka-Scheibe J, Pawlukojć A, Maurin JK, Schilf W.
PMID: 34198707
Materials (Basel). 2021 Jun 14;14(12). doi: 10.3390/ma14123292.

The new complex of N,N-Dimethylglycine (DMG) with chloranilic acid (CLA) was synthesized and examined for thermal, structural, and dynamical properties. The structure of the reaction product between DMG and CLA was investigated in a deuterated dimethyl sulfoxide (DMSO-d6) solution...

Cite
Hetmańczyk J, Hetmańczyk Ł, Nowicka-Scheibe J, et al. Structural, Thermal, and Vibrational Properties of N,N-Dimethylglycine-Chloranilic Acid-A New Co-Crystal Based on an Aliphatic Amino Acid. Materials (Basel). 2021;14(12)doi: 10.3390/ma14123292.
Hetmańczyk, J., Hetmańczyk, �. �., Nowicka-Scheibe, J., Pawlukojć, A., Maurin, J. K., & Schilf, W. (2021). Structural, Thermal, and Vibrational Properties of N,N-Dimethylglycine-Chloranilic Acid-A New Co-Crystal Based on an Aliphatic Amino Acid. Materials (Basel, Switzerland), 14(12), . https://doi.org/10.3390/ma14123292
Hetmańczyk, Joanna, et al. "Structural, Thermal, and Vibrational Properties of N,N-Dimethylglycine-Chloranilic Acid-A New Co-Crystal Based on an Aliphatic Amino Acid." Materials (Basel, Switzerland) vol. 14,12 (2021). doi: https://doi.org/10.3390/ma14123292
Hetmańczyk J, Hetmańczyk Ł, Nowicka-Scheibe J, Pawlukojć A, Maurin JK, Schilf W. Structural, Thermal, and Vibrational Properties of N,N-Dimethylglycine-Chloranilic Acid-A New Co-Crystal Based on an Aliphatic Amino Acid. Materials (Basel). 2021 Jun 14;14(12). doi: 10.3390/ma14123292. PMID: 34198707; PMCID: PMC8232199.
Copy Download .nbib Format: NLM
Use of the Levonorgestrel Intrauterine System to Treat Heavy Menstrual Bleeding in Adolescents and Young Adults with Inherited Bleeding Disorders and Ehlers-Danlos Syndrome.

Journal of pediatric and adolescent gynecology

Huguelet PS, Laurin JL, Thornhill D, Moyer G.
PMID: 34775059
J Pediatr Adolesc Gynecol. 2021 Nov 11; doi: 10.1016/j.jpag.2021.11.002. Epub 2021 Nov 11.

STUDY OBJECTIVE: To report on the rate of amenorrhea among adolescents and young adults with a bleeding diathesis after insertion of the 52mg levonorgestrel intrauterine system (LNG-IUS).DESIGN: Retrospective chart review.SETTING: Tertiary care, multidisciplinary Gynecology-Hematology Clinic or Adolescent Gynecology clinic.PARTICIPANTS:...

Cite
Huguelet PS, Laurin JL, Thornhill D, et al. Use of the Levonorgestrel Intrauterine System to Treat Heavy Menstrual Bleeding in Adolescents and Young Adults with Inherited Bleeding Disorders and Ehlers-Danlos Syndrome. J Pediatr Adolesc Gynecol. 2021;doi: 10.1016/j.jpag.2021.11.002.
Huguelet, P. S., Laurin, J. L., Thornhill, D., & Moyer, G. (2021). Use of the Levonorgestrel Intrauterine System to Treat Heavy Menstrual Bleeding in Adolescents and Young Adults with Inherited Bleeding Disorders and Ehlers-Danlos Syndrome. Journal of pediatric and adolescent gynecology, . https://doi.org/10.1016/j.jpag.2021.11.002
Huguelet, P S, et al. "Use of the Levonorgestrel Intrauterine System to Treat Heavy Menstrual Bleeding in Adolescents and Young Adults with Inherited Bleeding Disorders and Ehlers-Danlos Syndrome." Journal of pediatric and adolescent gynecology vol. (2021). doi: https://doi.org/10.1016/j.jpag.2021.11.002
Huguelet PS, Laurin JL, Thornhill D, Moyer G. Use of the Levonorgestrel Intrauterine System to Treat Heavy Menstrual Bleeding in Adolescents and Young Adults with Inherited Bleeding Disorders and Ehlers-Danlos Syndrome. J Pediatr Adolesc Gynecol. 2021 Nov 11; doi: 10.1016/j.jpag.2021.11.002. Epub 2021 Nov 11. PMID: 34775059.
Copy Download .nbib Format: NLM
[Critical patients COVID-19 Has changed the management and outcomes in the ICU after 1 year of the pandemic?A multicenter, prospective, observational study].

Enfermedades infecciosas y microbiologia clinica (English ed.)

Rama-Maceiras P, Sanduende Y, Taboada M, Casero M, Leal S, Pita-Romero R, Fernández R, López E, Antonio López J, Pita E, Tubío A, Rodríguez A, Varela M, Campaña D, Delgado C, Lombardía M, Villar E, Blanco P, Martínez A, Sarmiento A, Díaz P, Ojea M, Rodríguez Á, Mouriz L, Cid M, Ramos L, Seoane-Pillado T.
PMID: 34305229
Enferm Infecc Microbiol Clin (Engl Ed). 2021 Jul 19; doi: 10.1016/j.eimc.2021.06.016. Epub 2021 Jul 19.

OBJECTIVE: To compare the clinical characteristics, treatments, and evolution of critical patients with COVID-19 pneumonia treated in Intensive Care Units (ICU) after one year of pandemic.METHODOLOGY: Multicenter, prospective study, which included critical COVID-19 patients in 9 ICUs in northwestern...

Cite
Rama-Maceiras P, Sanduende Y, Taboada M, et al. Pacientes críticos COVID-19 ¿Ha variado el manejo y resultados en la UCI tras 1 año de pandemia? Estudio multicéntrico, prospectivo, observacional. [Critical patients COVID-19 Has changed the management and outcomes in the ICU after 1 year of the pandemic?A multicenter, prospective, observational study]. Enferm Infecc Microbiol Clin (Engl Ed). 2021;doi: 10.1016/j.eimc.2021.06.016.
Rama-Maceiras, P., Sanduende, Y., Taboada, M., Casero, M., Leal, S., Pita-Romero, R., Fernández, R., López, E., Antonio López, J., Pita, E., Tubío, A., Rodríguez, A., Varela, M., Campaña, D., Delgado, C., Lombardía, M., Villar, E., Blanco, P., Martínez, A., Sarmiento, A., Díaz, P., Ojea, M., Rodríguez, �. �., Mouriz, L., Cid, M., Ramos, L., & Seoane-Pillado, T. (2021). Pacientes críticos COVID-19 ¿Ha variado el manejo y resultados en la UCI tras 1 año de pandemia? Estudio multicéntrico, prospectivo, observacional. [Critical patients COVID-19 Has changed the management and outcomes in the ICU after 1 year of the pandemic?A multicenter, prospective, observational study]. Enfermedades infecciosas y microbiologia clinica (English ed.), . https://doi.org/10.1016/j.eimc.2021.06.016
Rama-Maceiras, Pablo, et al. "Pacientes críticos COVID-19 ¿Ha variado el manejo y resultados en la UCI tras 1 año de pandemia? Estudio multicéntrico, prospectivo, observacional." [Critical patients COVID-19 Has changed the management and outcomes in the ICU after 1 year of the pandemic?A multicenter, prospective, observational study]. Enfermedades infecciosas y microbiologia clinica (English ed.) vol. (2021). doi: https://doi.org/10.1016/j.eimc.2021.06.016
Rama-Maceiras P, Sanduende Y, Taboada M, Casero M, Leal S, Pita-Romero R, Fernández R, López E, Antonio López J, Pita E, Tubío A, Rodríguez A, Varela M, Campaña D, Delgado C, Lombardía M, Villar E, Blanco P, Martínez A, Sarmiento A, Díaz P, Ojea M, Rodríguez Á, Mouriz L, Cid M, Ramos L, Seoane-Pillado T. Pacientes críticos COVID-19 ¿Ha variado el manejo y resultados en la UCI tras 1 año de pandemia? Estudio multicéntrico, prospectivo, observacional. [Critical patients COVID-19 Has changed the management and outcomes in the ICU after 1 year of the pandemic?A multicenter, prospective, observational study]. Enferm Infecc Microbiol Clin (Engl Ed). 2021 Jul 19; doi: 10.1016/j.eimc.2021.06.016. Epub 2021 Jul 19. Spanish. PMID: 34305229; PMCID: PMC8286862.
Copy Download .nbib Format: NLM
The Beta-Tubulin Isotype TUBB6 Controls Microtubule and Actin Dynamics in Osteoclasts.

Frontiers in cell and developmental biology

Maurin J, Morel A, Guérit D, Cau J, Urbach S, Blangy A, Bompard G.
PMID: 34869381
Front Cell Dev Biol. 2021 Nov 18;9:778887. doi: 10.3389/fcell.2021.778887. eCollection 2021.

Osteoclasts are bone resorbing cells that participate in the maintenance of bone health. Pathological increase in osteoclast activity causes bone loss, eventually resulting in osteoporosis. Actin cytoskeleton of osteoclasts organizes into a belt of podosomes, which sustains the bone...

Cite
Maurin J, Morel A, Guérit D, et al. The Beta-Tubulin Isotype TUBB6 Controls Microtubule and Actin Dynamics in Osteoclasts. Front Cell Dev Biol. 2021;9:778887doi: 10.3389/fcell.2021.778887.
Maurin, J., Morel, A., Guérit, D., Cau, J., Urbach, S., Blangy, A., & Bompard, G. (2021). The Beta-Tubulin Isotype TUBB6 Controls Microtubule and Actin Dynamics in Osteoclasts. Frontiers in cell and developmental biology, 9778887. https://doi.org/10.3389/fcell.2021.778887
Maurin, Justine, et al. "The Beta-Tubulin Isotype TUBB6 Controls Microtubule and Actin Dynamics in Osteoclasts." Frontiers in cell and developmental biology vol. 9 (2021): 778887. doi: https://doi.org/10.3389/fcell.2021.778887
Maurin J, Morel A, Guérit D, Cau J, Urbach S, Blangy A, Bompard G. The Beta-Tubulin Isotype TUBB6 Controls Microtubule and Actin Dynamics in Osteoclasts. Front Cell Dev Biol. 2021 Nov 18;9:778887. doi: 10.3389/fcell.2021.778887. eCollection 2021. PMID: 34869381; PMCID: PMC8639228.
Copy Download .nbib Format: NLM
Use of the Levonorgestrel Intrauterine System to Treat Heavy Menstrual Bleeding in Adolescents and Young Adults with Inherited Bleeding Disorders and Ehlers-Danlos Syndrome.

Journal of pediatric and adolescent gynecology

Huguelet PS, Laurin JL, Thornhill D, Moyer G.
PMID: 34775059
J Pediatr Adolesc Gynecol. 2021 Nov 11; doi: 10.1016/j.jpag.2021.11.002. Epub 2021 Nov 11.

STUDY OBJECTIVE: To report on the rate of amenorrhea among adolescents and young adults with a bleeding diathesis after insertion of the 52-mg levonorgestrel intrauterine system (LNG-IUS) DESIGN: Retrospective chart review SETTING: Tertiary care, multidisciplinary Gynecology-Hematology clinic or Adolescent...

Cite
Huguelet PS, Laurin JL, Thornhill D, et al. Use of the Levonorgestrel Intrauterine System to Treat Heavy Menstrual Bleeding in Adolescents and Young Adults with Inherited Bleeding Disorders and Ehlers-Danlos Syndrome. J Pediatr Adolesc Gynecol. 2021;doi: 10.1016/j.jpag.2021.11.002.
Huguelet, P. S., Laurin, J. L., Thornhill, D., & Moyer, G. (2021). Use of the Levonorgestrel Intrauterine System to Treat Heavy Menstrual Bleeding in Adolescents and Young Adults with Inherited Bleeding Disorders and Ehlers-Danlos Syndrome. Journal of pediatric and adolescent gynecology, . https://doi.org/10.1016/j.jpag.2021.11.002
Huguelet, Patricia S, et al. "Use of the Levonorgestrel Intrauterine System to Treat Heavy Menstrual Bleeding in Adolescents and Young Adults with Inherited Bleeding Disorders and Ehlers-Danlos Syndrome." Journal of pediatric and adolescent gynecology vol. (2021). doi: https://doi.org/10.1016/j.jpag.2021.11.002
Huguelet PS, Laurin JL, Thornhill D, Moyer G. Use of the Levonorgestrel Intrauterine System to Treat Heavy Menstrual Bleeding in Adolescents and Young Adults with Inherited Bleeding Disorders and Ehlers-Danlos Syndrome. J Pediatr Adolesc Gynecol. 2021 Nov 11; doi: 10.1016/j.jpag.2021.11.002. Epub 2021 Nov 11. PMID: 34775059.
Copy Download .nbib Format: NLM
Revascularized ST-segment elevation myocardial infarction. Temporal trends in contemporary therapies and impact on outcomes.

Revista espanola de cardiologia (English ed.)

Ribera A, Marsal JR, Faixedas MT, Rosas A, Tizón-Marcos H, Rojas S, Labata C, Cárdenas M, Homs S, Tomás-Querol C, García-Picart J, Roura G, Masotti M, Mauri J, Pijoan JI, Barrabés JA, Ferreira-González I.
PMID: 34887210
Rev Esp Cardiol (Engl Ed). 2021 Dec 06; doi: 10.1016/j.rec.2021.10.011. Epub 2021 Dec 06.

INTRODUCTION AND OBJECTIVES: To assess, in patients with ST-segment elevation myocardial infarction (STEMI) who underwent primary percutaneous intervention, the pace of introduction in clinical practice (2010-2017) of drug-eluting stents (DES), ticagrelor, prasugrel, and prolonged dual antiplatelet therapy (DAPT) duration,...

Cite
Ribera A, Marsal JR, Faixedas MT, et al. Revascularized ST-segment elevation myocardial infarction. Temporal trends in contemporary therapies and impact on outcomes. Rev Esp Cardiol (Engl Ed). 2021;doi: 10.1016/j.rec.2021.10.011.
Ribera, A., Marsal, J. R., Faixedas, M. T., Rosas, A., Tizón-Marcos, H., Rojas, S., Labata, C., Cárdenas, M., Homs, S., Tomás-Querol, C., García-Picart, J., Roura, G., Masotti, M., Mauri, J., Pijoan, J. I., Barrabés, J. A., Ferreira-González, I. (2021). Revascularized ST-segment elevation myocardial infarction. Temporal trends in contemporary therapies and impact on outcomes. Revista espanola de cardiologia (English ed.), . https://doi.org/10.1016/j.rec.2021.10.011
Ribera, Aida, et al. "Revascularized ST-segment elevation myocardial infarction. Temporal trends in contemporary therapies and impact on outcomes." Revista espanola de cardiologia (English ed.) vol. (2021). doi: https://doi.org/10.1016/j.rec.2021.10.011
Ribera A, Marsal JR, Faixedas MT, Rosas A, Tizón-Marcos H, Rojas S, Labata C, Cárdenas M, Homs S, Tomás-Querol C, García-Picart J, Roura G, Masotti M, Mauri J, Pijoan JI, Barrabés JA, Ferreira-González I. Revascularized ST-segment elevation myocardial infarction. Temporal trends in contemporary therapies and impact on outcomes. Rev Esp Cardiol (Engl Ed). 2021 Dec 06; doi: 10.1016/j.rec.2021.10.011. Epub 2021 Dec 06. Spanish. PMID: 34887210.
Copy Download .nbib Format: NLM
Procedural Results and One-Year Clinical Outcomes of Treatment of Bioresorbable Vascular Scaffolds Restenosis (from the RIBS VII Prospective Study).

The American journal of cardiology

Alfonso F, Cuesta J, Ojeda S, Camacho-Freire S, García Del Blanco B, Vaquerizo B, Zueco J, Trillo R, Mauri J, Velázquez M, Córdoba-Soriano JG, Serra A, Navarro F, Pan M, Díaz J, Otaegui I, Salvatella N, De la TorreHernandez JM, Val DD, Bastante T, Rivero F.
PMID: 34903344
Am J Cardiol. 2022 Jan 01;162:31-40. doi: 10.1016/j.amjcard.2021.09.027.

Currently, both drug-eluting stents (DES) and drug-eluting balloons are recommended in patients with in-stent restenosis (ISR) of metallic stents. However, the clinical results of repeated interventions in patients with restenosis of bioresorbable vascular scaffolds (BVS) remain unsettled. We sought...

Cite
Alfonso F, Cuesta J, Ojeda S, et al. Procedural Results and One-Year Clinical Outcomes of Treatment of Bioresorbable Vascular Scaffolds Restenosis (from the RIBS VII Prospective Study). Am J Cardiol. 2022;162:31-40doi: 10.1016/j.amjcard.2021.09.027.
Alfonso, F., Cuesta, J., Ojeda, S., Camacho-Freire, S., García Del Blanco, B., Vaquerizo, B., Zueco, J., Trillo, R., Mauri, J., Velázquez, M., Córdoba-Soriano, J. G., Serra, A., Navarro, F., Pan, M., Díaz, J., Otaegui, I., Salvatella, N., De la TorreHernandez, J. M., Val, D. D., Bastante, T., Rivero, F. (2022). Procedural Results and One-Year Clinical Outcomes of Treatment of Bioresorbable Vascular Scaffolds Restenosis (from the RIBS VII Prospective Study). The American journal of cardiology, 16231-40. https://doi.org/10.1016/j.amjcard.2021.09.027
Alfonso, Fernando, et al. "Procedural Results and One-Year Clinical Outcomes of Treatment of Bioresorbable Vascular Scaffolds Restenosis (from the RIBS VII Prospective Study)." The American journal of cardiology vol. 162 (2022): 31-40. doi: https://doi.org/10.1016/j.amjcard.2021.09.027
Alfonso F, Cuesta J, Ojeda S, Camacho-Freire S, García Del Blanco B, Vaquerizo B, Zueco J, Trillo R, Mauri J, Velázquez M, Córdoba-Soriano JG, Serra A, Navarro F, Pan M, Díaz J, Otaegui I, Salvatella N, De la TorreHernandez JM, Val DD, Bastante T, Rivero F. Procedural Results and One-Year Clinical Outcomes of Treatment of Bioresorbable Vascular Scaffolds Restenosis (from the RIBS VII Prospective Study). Am J Cardiol. 2022 Jan 01;162:31-40. doi: 10.1016/j.amjcard.2021.09.027. PMID: 34903344.
Copy Download .nbib Format: NLM
Showing 145 to 153 of 153 entries